Beatriz Lara

1.9k citations
45 papers · 1.0k indexed · h-index 19
Topics
Protease and Inhibitor Mechanisms (21 papers)Peptidase Inhibition and Analysis (19 papers)Pulmonary Hypertension Research and Treatments (13 papers)
Partner nations
SpainUnited KingdomItaly

In The Last Decade

Beatriz Lara

43 papers receiving 984 citations

Peers

Beatriz Lara
Comparison fields: 5 of 104
  • Cancer Research 424
  • Oncology 372
  • Pulmonary and Respiratory Medicine 264
  • Molecular Biology 237
  • Hematology 161
Replace Fuat Oduncu with:
Fuat Oduncu Germany
Thomas Bradley United States
Tracey O’Brien Australia
Adrienne Morgan United Kingdom
Anne Letsch Germany
Sergio Facchini Italy
Laura J. Rush United States
Vassilios Papadakis Greece
Parkin Dm France
Beatriz Lara relative to Fuat Oduncu Germany Fuat Oduncu's profile →
Citations per field
00.5×5.4×
Fuat Oduncu · 1×
Citations per year

Countries citing papers authored by Beatriz Lara

Since Specialization
Citations

This map shows the geographic impact of Beatriz Lara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beatriz Lara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beatriz Lara more than expected).

Fields of papers citing papers by Beatriz Lara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beatriz Lara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beatriz Lara. The network helps show where Beatriz Lara may publish in the future.

Co-authorship network of co-authors of Beatriz Lara

This figure shows the co-authorship network connecting the top 25 collaborators of Beatriz Lara. A scholar is included among the top collaborators of Beatriz Lara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beatriz Lara. Beatriz Lara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 7
4 126
5 6
6 19
7 11
8 9
9 29
10 31
11 51
12 27
13 7
14 47
15 14
16 16
17 12
18 12
19 105
20 12

About Beatriz Lara

Beatriz Lara is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 1.0k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (21 papers), Peptidase Inhibition and Analysis (19 papers) and Pulmonary Hypertension Research and Treatments (13 papers). The work is most often cited by research in Cancer Research (424 citations), Hematology (161 citations) and Oncology (372 citations). Beatriz Lara has collaborated with scholars based in Spain, United Kingdom and Italy. Frequent co-authors include Marc Miravitlles, Ignacio Blanco, Gerard Piñol‐Ripoll, Iván D. Benítez, Anna Carnes, Farida Dakterzada, María Teresa Martínez, Juan A. Ayala, Cristian de la Roza and Francisco Casas Maldonado. Their work appears in journals such as PLoS ONE, Molecular Microbiology and European Respiratory Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026